Program to manage fear of cancer recurrence in patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a program designed to implement screening, referral, and management of fear of cancer recurrence in routine cancer care clinics. It employs a stepped-wedge cluster randomized controlled trial approach to compare the effectiveness of systematic implementation strategies against usual care. The program includes training and qualitative assessments to understand the experiences of patients and service providers, as well as to identify factors that may affect its adoption and sustainability. The goal is to increase the number of eligible patients screened and referred for psychosocial support.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients diagnosed with non-metastatic breast, gynecological, or colorectal cancer, and who have completed primary and adjuvant treatment within the past two years will be eligible for the proposed screening program.

Exclusion Criteria:

* All cancer patients beyond two years post-treatment; and diagnosed with metastatic cancer or non-breast, non-gynecological, and non-colorectal cancer.

Where it's running

• KWH Breast clinic
  Hong Kong, Hong Kong Recruiting
• QMH department of Surgery
  Hong Kong, Hong Kong Recruiting

Study contacts

• Principal investigator: Danielle Ng, PhD — The University of Hong Kong
• Study coordinator: Danielle Ng, Phd
• Email: dwlng@hku.hk
• Phone: +852 39179897

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Patient-partnered look at fear of cancer returning after kidney cancer surgery

  This project will work with people who had kidney cancer surgery and their partners to see if patient-led questions, timing, and digital methods can better identify fear that the cancer will come back.

  Recruiting at 3 sites Gødstrup Hospital · Aalborg and 2 other locations · NCT07234656

• Parent-FORT: Fear of Cancer Recurrence therapy for parents of childhood cancer survivors

  This pilot tests a virtual group therapy called Parent-FORT to see if it reduces fear of cancer recurrence and improves quality of life for parents of childhood cancer survivors.

  Recruiting University of Ottawa · Ottawa, Ontario · NCT06872840

• Adapted group cognitive-behavioral therapy for fear of cancer returning in women with BRCA1 or BRCA2 mutations

  This project tests an adapted group cognitive-behavioral therapy to reduce fear of cancer returning in women who carry BRCA1 or BRCA2 mutations and have finished primary treatment.

  Recruiting CHU de Quebec-Universite Laval · Québec, Quebec · NCT06817694

• EMDR treatment for fear of cancer recurrence in familial melanoma patients

  This study is testing if EMDR therapy can help patients with familial melanoma feel less afraid of their cancer coming back.

  Recruiting at 2 sites Leiden University Medical Center · Leiden, South Holland and 1 other locations · NCT06767332

• Managing fear of cancer recurrence in survivors through a stepped-care intervention

  This study is testing a new way to help cancer survivors manage their fear of cancer coming back by trying different support methods based on how they respond.

  Recruiting The University of Hong Kong · Hong Kong · NCT06181331

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.